04/03/2024

News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History

04/03/2024

Mar 4, 2024, 17:58 | Insight
Paolo Tarantino: You don’t always need a fancy new drug to impact patients QoL
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 4, 2024, 17:53 | Career
Karen Knudsen: It is such an honor to be named to the inaugural CNBC Change makers list alongside these incredible women
Karen Knudsen shared a post by CNBC on LinkedIn: ''It is such an honor to be…
Mar 4, 2024, 17:46 | Blog
Annalisa Saetta: Luckily I had mentors who showed me ladders to overcome the hurdles and go along with my research
Annalisa Saetta, Consultant Medical Oncologist and Palliative Care Specialist at Humanitas University, posted on LinkedIn:…
Mar 4, 2024, 17:40 | Insight
Humam Kadara: An atlas of normal and cancerous epithelial cells in lung adenocarcinoma
Humam Kadara, Professor of Translational Molecular Pathology at The University of Texas MD Anderson Cancer…
Mar 4, 2024, 17:37 | Blog
Histiocytosis Association: Inspirational stories from patients diagnosed as children in the Beyond the Diagnosis Podcast
Histiocytosis Association posted on LinkedIn: "Episode 062 of the Beyond the Diagnosis Podcast is now…
Mar 4, 2024, 17:34 | Insight
Jill Feldman: The importance of focusing on the 3 P's when discussing treatment options after a patient experiences progression on targeted therapy
Jill Feldman, Co-Founder of EGFR Resisters, posted on LinkedIn: "It was an honor to collaborate…
Mar 4, 2024, 17:27 | Drugs
Piotr Wysocki: Anthracyclines must always be considered in the adjuvant treatment of breast cancer patients- final results of ABC trials
Piotr Wysocki, Professor of Medicine and Head of Department of Oncology at Jagiellonian University Hospital…
Mar 4, 2024, 17:21 | Blog
Yin Ling Woo: I've participated in quite a few colposcopy courses this one was one of the best
Yin Ling Woo, Professor of Obstetrics and Gynaecology at University of Malaya, shared on LinkedIn:…
Mar 4, 2024, 17:11 | Blog
Laurie Glimcher: It is an honor to be recognized among so many talented leaders on the 2024 STATUS list
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: “It is an…
Mar 4, 2024, 17:07 | Drugs
George Mellgard: We delve into the complexities of FDA Accelerated Approvals in oncology using lessons from 16 withdrawn accelerated approvals in the past decade
George Mellgard, Medical Student at Columbia University Irving Medical Center in NYC, shared on X/Twitter:…
All: 26 Posts: 1 - 10